Antimicrobial Agents and Chemotherapy
Brief Name:
ANTIMICROB AGENTS CH
Impact factor:
4.1 (2023)
ISSN:
0066-4804
Home Page:
Open Access:
No
Publisher:
American Society for Microbiology
Publication Frequency:
Monthly
Article Processing Charge:
Member: $2,950; Non-member: $4,100
Publication Start Year:
1972
Annual Articles:
330
Self-citation Rate:
7.3%
Chinese Academy of Sciences SCI Journal Classification:
Major category | Minor category | TOP journal | Review journal |
---|---|---|---|
Q2 MEDICAL |
OF MICROBIOLOGY | Yes | No |
Subject Classification:
MICROBIOLOGY
CiteScore:
CiteScore | SJR | SNIP | CiteScore ranking | ||||||
---|---|---|---|---|---|---|---|---|---|
10 | 1.357 | 1.046 |
|
H-Index:
232
SCI Index Status:
Science Citation Index Expanded
Official Review Time:
Avg Days to First Decision: 42
Avg Days to Publication from Acceptance*: 11
PubMed Central:
Aims and Scope:
Antimicrobial Agents and Chemotherapy® is an interdisciplinary journal devoted to the dissemination of knowledge relating to all aspects of antimicrobial agents. Any report involving studies of or with antibacterial, antiviral (including antiretroviral), antifungal, or antiparasitic agents as these relate to human disease is within the purview of AAC.
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.